The PubMed record describes a randomized controlled trial published in Gut Microbes titled: “Synbiotic supplementation leads to gut microbiome communities with functional capacity linked to better brain white matter development in preterm infants.” The entry identifies the work as a clinical research study addressing the intersection of synbiotic supplementation, the gut microbiome, and early brain (white matter) development in preterm infants.
The bibliographic metadata available in the PubMed entry include journal, DOI, PMID, and publication timing (Epub 2026 Oct 7; citation listing 2026 Dec 31;18(1):2743949). The study is explicitly categorized as a Randomized Controlled Trial in the PubMed listing.
The PubMed page indicates this is an RCT in preterm infants, but the excerpt provided here does not include the study abstract or the trial methods. Specific details that are not reported in the supplied PubMed content include sample size, inclusion and exclusion criteria, gestational ages of enrolled infants, randomization procedures, blinding, enrollment dates, clinical sites beyond institutional affiliations, and follow-up duration. These trial-level design elements must be obtained from the full article for evaluation of internal validity and applicability.
The title asserts that synbiotic supplementation was the intervention of interest. However, the PubMed excerpt provided does not specify the synbiotic formulation, dose, timing, route of administration, duration of exposure, or the nature of any comparator (placebo, standard care, or alternative). The composition of the synbiotic (probiotic strains and prebiotic components) and any manufacturing or quality-control details are not reported in the source text available here.
According to the article title, the trial assessed gut microbiome community structure with attention to community-level functional capacity. The PubMed record does not include the assay methods (for example, 16S rRNA gene sequencing, metagenomics, metatranscriptomics, or functional inference tools), nor does it report specific taxa, functional pathways, timing of stool collection, or statistical analyses. Numerical findings, effect sizes, and measures of statistical significance for microbiome endpoints are not present in the provided content.
The title reports a link between microbiome functional capacity and better brain white matter development; however, the PubMed excerpt lacks descriptive or quantitative information on neuroimaging methods, imaging timing, imaging metrics (such as diffusion tensor imaging parameters), outcome definitions, and how brain white matter development was operationalized or analyzed. There are no reported imaging results, effect estimates, or details on whether clinical neurodevelopmental outcomes were assessed.
The PubMed entry lists a multi-author, multi-institution collaboration. Lead and contributing authors include Anna Voulgari-Kokota, Els Janson, Ineke Heikamp de Jong, Jan Knol, Ruurd van Elburg, Niek E van der Aa, Lisa M Hortensius, Jeroen Dudink, Caroline G M de Theije, and others. Affiliations span academic and clinical centers and industry research groups in the Netherlands: Laboratory of Microbiology (Wageningen University & Research), Department of Neonatology and University Medical Center Utrecht Brain Center (Wilhelmina Children's Hospital), Danone Research & Innovation, multiple pediatric departments across Dutch hospitals, Image Sciences Institute and radiology/biomedical engineering groups at Amsterdam and Utrecht centers.
The PubMed record provides PMID 42841652 and DOI 10.1080/19490976.2026.2743949 for locating the primary article.
The version of the PubMed page supplied here contains extensive bibliographic and author-affiliation metadata but does not include the article abstract or any primary data. Consequently, key elements needed to appraise the trial—sample size, protocol specifics, synbiotic composition and dosing, comparator details, microbiome laboratory methods, neuroimaging methodology, statistical analyses, and the actual results—are not available in the provided source excerpt.
Because these trial-critical data are absent from the supplied PubMed content, no additional factual statements about efficacy, safety, magnitude of associations, or mechanistic pathways can be made beyond the claims summarized in the article title.
For clinicians, researchers, or guideline developers seeking to evaluate the trial’s validity and applicability, consult the full text via the DOI (10.1080/19490976.2026.2743949) or the Gut Microbes journal site. The complete article will be required to review methods, numerical results, subgroup analyses, adverse events, and authors’ interpretations and limitations.
The PubMed record documents a randomized controlled trial reporting that synbiotic supplementation produced gut microbiome communities with a functional capacity associated with improved brain white matter development in preterm infants. The PubMed excerpt contains bibliographic data and full authorship and affiliation lists but does not provide the trial’s methods, data, or detailed results; those were not reported in the source content provided here and must be obtained from the full publication.